Status: Recruiting
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.
Participants needed: 132
Trial details
Phase: Phase 4Age: 6-11Biological sex: AllType: InterventionalSponsor: Upsher-Smith LaboratoriesUpdated: Jan 27, 2025Locations: 15
Eligibility criteria
Subject is a female or male 6 to 11 years of age, inclusive, at Visit 1 (Screeni... [+4]
Subject has continuous migraines, defined as an unrelenting headache for a 28-da... [+10]